Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications
Article in Journal of Medicinal Chemistry (June 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Modern Developments in Bifunctional Chelator Design for Gallium Radiopharmaceuticals
Article in Molecules (December 2022)
Novel Peptide-Based PET Probe for Non-invasive Imaging of C‑X‑C Chemokine Receptor Type 4 (CXCR4) in Tumors
Article in Journal of Medicinal Chemistry (March 2021)